Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-813160 in combination with chemotherapy or nivolumab in advanced colorectal and pancreatic cancers
NCT03184870Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2017
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of BMS-813160 in colorectal cancer (CRC), pancreatic cancer (PC), sponsored by Bristol Myers Squibb. Started Aug 2017; status: completed.
02
Drugs
BMS-813160
03
Conditions
colorectal cancer (CRC)pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03184870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03184870.